Very pleased to share our latest work published in The Lancet Microbe. This national collaborative effort was made possible by the incredible dynamism, expertise, and commitment of the ANRS-MIE network and participating centers across France. #RSV #Nirsevimab #PublicHealth #Virology #ANRS-MIE

Fantastic Flavivirus meeting ! Great science and great networking

Happy to share our preprint “ICU patients with influenza during 2025–26 : a French nationwide cohort study”, conducted within the SEVARVIR consortium, supported and funded by ANRS-MIE. Severe H3N2 in 25–26 (subclade K) did not worsen outcomes in ICU patients. www.medrxiv.org/content/10.6...

How do mRNA vaccines help fight cancer? A @nature.com paper today tells the story, one with big implications, as reviewed here erictopol.substack.com/p/how-mrna-v...

Not just shingles vaccine, but also RSV vaccine reduces the risk of dementia, which highlights the benefit of revving up the immune system in older individuals www.nature.com/articles/s41...

In some good news- this is an interesting idea. Lencapavirification (yes I made that term up) of flu antivirals: www.science.org/content/arti... Details on the drug here. www.nature.com/articles/s41...

Molecular characterization of RSV infections in elderly patients during the 2023/2024 season in the era of nirsevimab introduction ✅ Just Accepted #IDSky